Apigenin exerts protective effect and restores ovarian function in dehydroepiandrosterone induced polycystic ovary syndrome rats: a biochemical and histological analysis

References

• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis 1. Endocr Rev. 1997;18(6):774–800.
   PubMed Web of Science ®Google Scholar
• Rotterdam E. ASRM-sponsored P: revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41.
   PubMed Web of Science ®Google Scholar
• Abtahi-Eivari SH, Moghimian M, Soltani M, et al. The effect of Galega officinalis on hormonal and metabolic profile in a rat model of polycystic ovary syndrome. Int J Womens Health Reprod Sci. 2017;6(3):276–282.
   Web of Science ®Google Scholar
• Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439–451.
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale H, Villuendas G, Botella-Carretero J, et al. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study. Hum Reprod. 2006;21(9):2257–2265.
   PubMed Web of Science ®Google Scholar
• Gambineri A, Pelusi C, Vicennati V, et al. Obesity and the polycystic ovary syndrome. Int J Obes. 2002;26:883.
   PubMed Web of Science ®Google Scholar
• Kraus S, Naor Z, Seger R. Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor. Arch Med Res. 2001;32(6):499–509.
   PubMed Web of Science ®Google Scholar
• Legro RS, Arslanian SA, Ehrmann DA, Hoeger KM, et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013;98(12):4565–4592.
   PubMed Web of Science ®Google Scholar
• Lashen H. Role of metformin in the management of polycystic ovary syndrome. Ther Adv in Endocrinol Metab. 2010;1(3):117–128.
   PubMedGoogle Scholar
• Cibula D, Fanta M, Vrbikova J, et al. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients. Hum Reprod. 2005;20(1):180–184.
   PubMed Web of Science ®Google Scholar
• Palomba S, Falbo A, Zullo F, et al. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev. 2009;30(1):1–50.
   PubMed Web of Science ®Google Scholar
• Fenkci V, Fenkci S, Yilmazer M, et al. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril. 2003;80(1):123–127.
   PubMed Web of Science ®Google Scholar
• Verit FF, Erel O. Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters. Gynecol Obstet Investig. 2008;65(4):233–239.
   PubMed Web of Science ®Google Scholar
• Sies H. Oxidative stress: from basic research to clinical application. Am J Med. 1991;91(3):S31–S38.
   Web of Science ®Google Scholar
• Pisoschi AM, Pop A. The role of antioxidants in the chemistry of oxidative stress: a review. Eur J Med Chem. 2015;97:55–74.
   PubMed Web of Science ®Google Scholar
• De Bont R, van Larebeke N. Endogenous DNA damage in humans: a review of quantitative data. Mutagenesis. 2004;19(3):169–185.
   PubMed Web of Science ®Google Scholar
• Hiraku Y, Kawanishi S. Immunohistochemical analysis of 8-nitroguanine, a nitrative DNA lesion, in relation to inflammation-associated carcinogenesis. Methods Mol Biol. 2009;512:3–13.
   PubMedGoogle Scholar
• Dalle-Donne I, Rossi R, Giustarini D, et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta. 2003;329(1–2):23–38.
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Giustarini D, Colombo R, et al. Protein carbonylation in human diseases. Trends Mol Med. 2003;9(4):169–176.
   PubMed Web of Science ®Google Scholar
• Dalle-Donne I, Rossi R, Colombo R, et al. Biomarkers of oxidative damage in human disease. Clin Chem. 2006;52(4):601–623.
   PubMed Web of Science ®Google Scholar
• Tezil T, Basaga H. Modulation of cell death in age-related diseases. Curr Pharm Des. 2014;20(18):3052–3067.
   PubMed Web of Science ®Google Scholar
• Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and Meta-analysis. Hum Reprod Update. 2013;19(3):268–288.
   PubMed Web of Science ®Google Scholar
• Fader AN, Arriba LN, Frasure HE, et al. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol. 2009;114(1):121–127.
   PubMed Web of Science ®Google Scholar
• Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2005;3(1):28.
   PubMedGoogle Scholar
• Desai BN, Maharjan RH, Nampoothiri LP. Aloe barbadensis Mill. Formulation restores lipid profile to normal in a letrozole-induced polycystic ovarian syndrome rat model. Pharm Res. 2012;4(2):109.
   Google Scholar
• Khodaeifar F, Bagher Fazljou SM, Khaki A, et al. Investigating the role of hydroalcoholic extract of Apium graveolens and Cinnamon zeylanicum on metabolically change and ovarian oxidative injury in a rat model of polycystic ovary syndrome. Int J Womens Health Reprod Sci. 2018;7(1):92–98.
   Web of Science ®Google Scholar
• Jahan S, Munir F, Razak S, et al. Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats. J Ovarian Res. 2016;9:86.
   PubMed Web of Science ®Google Scholar
• Ali F, Naz F, Jyoti S, et al. Health functionality of apigenin: a review. Int J Food Prop. 2017;20:1197–1238.
   Web of Science ®Google Scholar
• Lotha R, Sivasubramanian A. Flavonoids nutraceuticals in prevention and treatment of cancer: a review. Asian J Pharm Clin Res. 2018;11(1):42–47.
   Google Scholar
• Zhang K, Song W, Li D, et al. Apigenin in the regulation of cholesterol metabolism and protection of blood vessels. Exp Ther Med. 2017;13(5):1719–1724.
   PubMed Web of Science ®Google Scholar
• Kim EJ, Jang M, Choi JH, et al. An improved dehydroepiandrosterone-induced rat model of polycystic ovary syndrome (PCOS): post-pubertal improve PCOS's features. Front Endocrinol. 2018;9:735.
   PubMed Web of Science ®Google Scholar
• Malik S, Suchal K, Khan SI, et al. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-kappaB-TNF-alpha and TGF-beta1-MAPK-fibronectin pathways. Am J Physiol Ren Physiol. 2017;313(2):F414–F422.
   PubMed Web of Science ®Google Scholar
• Shorr E. A new technic for staining vaginal smears: III, a single differential stain. Science. 1941;94:545–546.
   PubMedGoogle Scholar
• Luo L, Huang J, Fu Y, et al. Effects of tea polyphenols on ovarian development in rats. J Endocrinol Investig. 2008;31(12):1110–1118.
   PubMed Web of Science ®Google Scholar
• Franks S. Do animal models of polycystic ovary syndrome help to understand its pathogenesis and management? Yes, but their limitations should be recognized. Endocrinology. 2009; 150:3983–3985.
   PubMed Web of Science ®Google Scholar
• Paixão L, Ramos RB, Lavarda A, et al. Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review. Reprod Biol Endocrinol. 2017; 15:12.
   PubMed Web of Science ®Google Scholar
• Su T, Huang C, Yang C, et al. Apigenin inhibits STAT3/CD36 signaling axis and reduces visceral obesity. Pharmacol Res. 2020;152:104586.
   PubMed Web of Science ®Google Scholar
• Yang M, Jiang ZH, Li CG, et al. Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway. Biomed Pharmacother. 2018;105:1283–1290.
   PubMed Web of Science ®Google Scholar
• Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25(1):4–7.
   PubMed Web of Science ®Google Scholar
• Ren B, Qin W, Wu F, et al. Apigenin and naringenin regulate glucose and lipid metabolism, and ameliorate vascular dysfunction in type 2 diabetic rats. Eur J Pharmacol. 2016;773:13–23.
   PubMed Web of Science ®Google Scholar
• Marrano N, Spagnuolo R, Biondi G, et al. Effects of extra virgin olive oil polyphenols on beta-cell function and survival. Plants. 2021;10(2):286.
   Google Scholar
• Yeon Lee J, Baw CK, Gupta S, et al. Role of oxidative stress in polycystic ovary syndrome. CWHR. 2010;6(2):96–107.
   Google Scholar
• Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstetrics Gynaecol. 2011;25(3):287–299.
   PubMed Web of Science ®Google Scholar
• Jung WW. Protective effect of apigenin against oxidative stress-induced damage in osteoblastic cells. Int J Mol Med. 2014;33(5):1327–1334.
   PubMed Web of Science ®Google Scholar
• González F, Rote NS, Minium J, et al. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J Clin Endocrinol Metab. 2006;91(1):336–340.
   PubMed Web of Science ®Google Scholar
• Yildirim B, Demir S, Temur I, et al. Lipid peroxidation in follicular fluid of women with polycystic ovary syndrome during assisted reproduction cycles. J Reprod Med. 2007;52(8):722–726.
   PubMed Web of Science ®Google Scholar
• Sasikala S, Shamila S. Unique rat model exhibiting biochemical fluctuations of letrozole induced polycystic ovary syndrome and subsequent treatment with allopathic and ayurvedic medicines. J Cell Tissue Res. 2009;9(3):2013.
   Google Scholar
• Mendonça H, Montenegro Junior R, Foss M, et al. Positive correlation of serum leptin with estradiol levels in patients with polycystic ovary syndrome. Braz J Med Biol Res. 2004;37(5):729–736.
   PubMed Web of Science ®Google Scholar
• Doi SA, Al-Zaid M, Towers PA, et al. Irregular cycles and steroid hormones in polycystic ovary syndrome. Hum Reprod. 2005;20(9):2402–2408.
   PubMed Web of Science ®Google Scholar
• Fukuda S, Orisaka M, Tajima K, et al. Luteinizing hormoneinduced akt phosphorylation and androgen production are modulated by MAP kinase in bovine theca cells. J Ovarian Res. 2009;2(1):17.
   PubMed Web of Science ®Google Scholar
• Bogovich K, Richards JS. Androgen biosynthesis in developing ovarian follicles evidence that luteinizing hormone regulates thecal 17α-hydroxylase and C17–2o-Lyase activities. Endocrinology. 1982;111(4):1201–1208.
   PubMed Web of Science ®Google Scholar
• Wickenheisser JK, Nelson-DeGrave VL, McAllister JM. Dysregulation of cytochrome P450 17α-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(3):1720–1727.
   PubMed Web of Science ®Google Scholar
• Ghowsi M, Khazali H, Sisakhtnezhad S. Evaluation of TNF-α and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol. Iran J Basic Med Sci. 2018;21(2):165–174.
   PubMed Web of Science ®Google Scholar
• Rezvanfar M, Ahmadi A, Saadi HS, et al. Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone. Hum Exp Toxicol. 2012;31(9):887–897.
   PubMed Web of Science ®Google Scholar
• Stocco C, Telleria C, Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr Rev. 2007;28(1):117–149.
   PubMed Web of Science ®Google Scholar
• Ainehchi N, Khaki A, Ouladsahebmadarek E, et al. The effect of clomiphene citrate, herbal mixture, and herbal mixture along with clomiphene citrate on clinical and para-clinical parameters in infertile women with polycystic ovary syndrome: a randomized controlled clinical trial. AOMS. 2020;16(6):1304–1318.
   Google Scholar